Bioelectric impedance spectroscopy underestimates fat-free mass compared to dual energy X-ray absorptiometry in incurable cancer patients.
about
Measurement of body composition as a surrogate evaluation of energy balance in obese patientsThe cachexia score (CASCO): a new tool for staging cachectic cancer patients.The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review.The Role of Body Fat and Fat Distribution in Hypertension Risk in Urban Black South African WomenMeasuring body composition using the bioelectrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer.Prediction of limb lean tissue mass from bioimpedance spectroscopy in persons with chronic spinal cord injury.A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer.Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review.Bioimpedance at the bedside: current applications, limitations, and opportunities.Body fat and fat-free mass measured by bioelectric impedance spectroscopy and dual-energy X-ray absorptiometry in obese and non-obese adults.Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool.Dudrick Research Symposium 2015-Lean Tissue and Protein in Health and Disease.Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach.Chest computed tomography-derived low fat-free mass index and mortality in COPD.Body composition in overweight and obese women postpartum: bioimpedance methods validated by dual energy X-ray absorptiometry and doubly labeled water.Development of a single-frequency bioimpedance prediction equation for fat-free mass in an adult Indigenous Australian population.
P2860
Q26862846-A278CAA7-68E4-4BF3-B3B7-898D9A8D6C95Q34201322-93655825-5997-4FC6-B03A-CBA80BA5029BQ35721532-34433B47-6434-453B-950B-57B6D1414B06Q36015326-25DF3647-F73B-44C0-A951-1926BD9954F2Q36336092-F87E42C5-CE4A-4FF6-BE3A-40730E4CB89AQ37085939-3CAA7DF3-F071-4701-A51B-B602CD34F788Q38021854-D7D40637-500D-4575-8A73-E26D3BA423A1Q38255756-E3AB3349-C390-4DAC-8550-7EE1CCF50118Q38329318-5FAC79AB-665F-4BD4-ACB8-17EB2D673DDEQ38470809-3BB2B2D4-99E7-4B4F-8528-115FE8FEF3CDQ38928547-79EADDB2-1F1B-4FC7-B3B7-EDEDFF636CB0Q38930271-D67BD8FD-67FD-4C0B-9CA9-ECE3B4F83436Q39676975-901DDE81-DB16-4D19-B934-9EBA0FA55841Q47307473-245331AC-A693-4D09-A81A-C0068625694AQ50680160-3E97F420-ED1F-4A3A-96D0-28E016183200Q51092542-5240C6CE-D269-42B6-99B7-085DF30F81D9
P2860
Bioelectric impedance spectroscopy underestimates fat-free mass compared to dual energy X-ray absorptiometry in incurable cancer patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Bioelectric impedance spectros ...... in incurable cancer patients.
@en
Bioelectric impedance spectros ...... in incurable cancer patients.
@nl
type
label
Bioelectric impedance spectros ...... in incurable cancer patients.
@en
Bioelectric impedance spectros ...... in incurable cancer patients.
@nl
prefLabel
Bioelectric impedance spectros ...... in incurable cancer patients.
@en
Bioelectric impedance spectros ...... in incurable cancer patients.
@nl
P2093
P2860
P356
P1476
Bioelectric impedance spectros ...... in incurable cancer patients.
@en
P2093
P2860
P2888
P304
P356
10.1038/EJCN.2008.35
P577
2008-05-14T00:00:00Z
P5875
P6179
1019817066